Closed-loop ventilation mode (IntelliVent®-ASV) in intensive care unit: a randomized trial.
Émilie Bialais(Cliniques Universitaires Saint-Luc), Philippe Hantson, Laurence Vignaux, Xavier Wittebole(Cliniques Universitaires Saint-Luc), Marc Wysocki, Jean Roeseler(University Hospital of Geneva), Dominik Novotni, Johannes Meyer, Grégory Reychler(Cliniques Universitaires Saint-Luc), Thierry Sottiaux, Pierre‐François Laterre(Cliniques Universitaires Saint-Luc)
PubMed
June 1, 2016
Cited by 37
Related Papers
Efficacy and Safety of Recombinant Human Activated Protein C for Severe Sepsis
|New England Journal of Medicine|2001|6.1k
High-Flow Oxygen through Nasal Cannula in Acute Hypoxemic Respiratory Failure
|New England Journal of Medicine|2015|2.4k
Drotrecogin Alfa (Activated) for Adults with Severe Sepsis and a Low Risk of Death
|New England Journal of Medicine|2005|890